Ma R, Xu X
Cancer Gene Ther. 2024; 31(8):1113-1123.
PMID: 38879655
DOI: 10.1038/s41417-024-00797-1.
Wang Y, Zou H, Ji W, Huang M, You B, Sun N
Cancer Biol Ther. 2024; 25(1):2323768.
PMID: 38465861
PMC: 10936631.
DOI: 10.1080/15384047.2024.2323768.
Vriend J, Thanasupawat T, Sinha N, Klonisch T
Int J Mol Sci. 2022; 23(20).
PMID: 36293188
PMC: 9604155.
DOI: 10.3390/ijms232012330.
Krishna A, John S, Shinde P, Mishra R
Cancer Cell Int. 2021; 21(1):575.
PMID: 34715855
PMC: 8555349.
DOI: 10.1186/s12935-021-02279-y.
Higginbotham J, OShea C
J Virol. 2015; 89(20):10260-72.
PMID: 26223632
PMC: 4580165.
DOI: 10.1128/JVI.01091-15.
NKG2D and DNAM-1 Ligands: Molecular Targets for NK Cell-Mediated Immunotherapeutic Intervention in Multiple Myeloma.
Fionda C, Soriani A, Zingoni A, Santoni A, Cippitelli M
Biomed Res Int. 2015; 2015:178698.
PMID: 26161387
PMC: 4486747.
DOI: 10.1155/2015/178698.
PML nuclear bodies: assembly and oxidative stress-sensitive sumoylation.
Sahin U, de The H, Lallemand-Breitenbach V
Nucleus. 2014; 5(6):499-507.
PMID: 25482067
PMC: 4615786.
DOI: 10.4161/19491034.2014.970104.
SUMOylation of ATRIP potentiates DNA damage signaling by boosting multiple protein interactions in the ATR pathway.
Wu C, Ouyang J, Mori E, Nguyen H, Marechal A, Hallet A
Genes Dev. 2014; 28(13):1472-84.
PMID: 24990965
PMC: 4083090.
DOI: 10.1101/gad.238535.114.
Sumoylation and the DNA damage response.
Cremona C, Sarangi P, Zhao X
Biomolecules. 2014; 2(3):376-388.
PMID: 24926426
PMC: 4030838.
DOI: 10.3390/biom2030376.
The DNA damage response: the omics era and its impact.
Derks K, Hoeijmakers J, Pothof J
DNA Repair (Amst). 2014; 19:214-20.
PMID: 24794401
PMC: 4088957.
DOI: 10.1016/j.dnarep.2014.03.008.
Targeted identification of SUMOylation sites in human proteins using affinity enrichment and paralog-specific reporter ions.
Lamoliatte F, Bonneil E, Durette C, Caron-Lizotte O, Wildemann D, Zerweck J
Mol Cell Proteomics. 2013; 12(9):2536-50.
PMID: 23750026
PMC: 3769329.
DOI: 10.1074/mcp.M112.025569.
Dual recruitment of Cdc48 (p97)-Ufd1-Npl4 ubiquitin-selective segregase by small ubiquitin-like modifier protein (SUMO) and ubiquitin in SUMO-targeted ubiquitin ligase-mediated genome stability functions.
Nie M, Aslanian A, Prudden J, Heideker J, Vashisht A, Wohlschlegel J
J Biol Chem. 2012; 287(35):29610-9.
PMID: 22730331
PMC: 3436128.
DOI: 10.1074/jbc.M112.379768.
RNF4, a SUMO-targeted ubiquitin E3 ligase, promotes DNA double-strand break repair.
Galanty Y, Belotserkovskaya R, Coates J, Jackson S
Genes Dev. 2012; 26(11):1179-95.
PMID: 22661229
PMC: 3371407.
DOI: 10.1101/gad.188284.112.
De-SUMOylation of CCCTC binding factor (CTCF) in hypoxic stress-induced human corneal epithelial cells.
Wang J, Wang Y, Lu L
J Biol Chem. 2012; 287(15):12469-79.
PMID: 22354964
PMC: 3320996.
DOI: 10.1074/jbc.M111.286641.
Expression profiling and pathway analysis of Krüppel-like factor 4 in mouse embryonic fibroblasts.
Hagos E, Ghaleb A, Kumar A, Neish A, Yang V
Am J Cancer Res. 2011; 1(1):85-97.
PMID: 21892412
PMC: 3165197.
Mutations in the BRCT binding site of BRCA1 result in hyper-recombination.
Dever S, Golding S, Rosenberg E, Adams B, Idowu M, Quillin J
Aging (Albany NY). 2011; 3(5):515-32.
PMID: 21666281
PMC: 3156602.
DOI: 10.18632/aging.100325.
DNA repair and global sumoylation are regulated by distinct Ubc9 noncovalent complexes.
Prudden J, Perry J, Nie M, Vashisht A, Arvai A, Hitomi C
Mol Cell Biol. 2011; 31(11):2299-310.
PMID: 21444718
PMC: 3133251.
DOI: 10.1128/MCB.05188-11.
Connecting the Dots: Interplay between Ubiquitylation and SUMOylation at DNA Double-Strand Breaks.
Tang J, Greenberg R
Genes Cancer. 2010; 1(7):787-96.
PMID: 21113239
PMC: 2989631.
DOI: 10.1177/1947601910382774.
The ubiquitous role of ubiquitin in the DNA damage response.
Al-Hakim A, Escribano-Diaz C, Landry M, ODonnell L, Panier S, Szilard R
DNA Repair (Amst). 2010; 9(12):1229-40.
PMID: 21056014
PMC: 7105183.
DOI: 10.1016/j.dnarep.2010.09.011.
DNA double-strand break signaling and human disorders.
Bohgaki T, Bohgaki M, Hakem R
Genome Integr. 2010; 1(1):15.
PMID: 21054854
PMC: 2993650.
DOI: 10.1186/2041-9414-1-15.